<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate CT colonography (CTC) performance for detecting and characterising synchronous lesions proximal to a stenosing <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and to suggest patient management strategies according to the CTC findings </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: 411 consecutive patients underwent CTC for proximal colonic evaluation after failed colonoscopy past a newly diagnosed stenosing <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Pathological examination of colectomy specimen and/or postsurgical colonoscopy with pathological confirmation of the proximal synchronous lesions to serve as reference standards existed in 284 patients </plain></SENT>
<SENT sid="3" pm="."><plain>Per-patient and per-lesion diagnostic performance measures of CTC for diagnosing proximal synchronous lesions ≥6 mm analysed by histopathological categories were obtained for the 284 patients </plain></SENT>
<SENT sid="4" pm="."><plain>Per-lesion sensitivity and positive predictive value (<z:chebi fb="0" ids="53261">PPV</z:chebi>) of various CTC lesion size criteria and lesion size combined with other CTC findings for diagnosing <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in the proximal colon were determined </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Both per-patient and per-lesion CTC detection sensitivities for proximal synchronous <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> were 100% (6/6 patients and 8/8 lesions; 95% CI 64.3% to 100% and 70.7% to 100%, respectively) with the corresponding per-patient negative predictive value (NPV) of a negative CTC of 100% (194/194 patients; 95% CI 98.3% to 100%) </plain></SENT>
<SENT sid="6" pm="."><plain>Per-patient NPV of a negative CTC for advanced <z:hpo ids='HP_0002664'>neoplasia</z:hpo> (ie, advanced <z:mpath ids='MPATH_270'>adenomas</z:mpath> and <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e>) was 97.4% (189/194 patients; 95% CI 93.9% to 99.1%) </plain></SENT>
<SENT sid="7" pm="."><plain>A lesion size ≥15 mm on CTC as the criterion to specifically diagnose proximal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> yielded 87.5% (7/8 lesions; 95% CI 50.8% to 99.9%) per-lesion sensitivity, rendering one 8-mm submucosal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> mischaracterised as a non-cancerous lesion, and 70% (7/10 lesions; 95% CI 39.2% to 89.7%) per-lesion <z:chebi fb="0" ids="53261">PPV</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>Additional CTC findings did not improve the sensitivity </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: CTC is highly sensitive in detecting synchronous <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> proximal to a stenosing <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>CTC has limited capability in differentiating advanced <z:mpath ids='MPATH_270'>adenomas</z:mpath> from <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and this compromises the <z:chebi fb="0" ids="53261">PPV</z:chebi> of CTC for the presence of proximal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
</text></document>